The TLX3 product consists of a 162kb probe, labelled in red, located centromeric to the TLX3 gene, including the middle part of the RANBP17 gene and the D5S653 marker and a green probe covering a 173kb region located telomeric to the gene, including the NPM1 and FGF18 genes and the RH80894 marker.
The TLX3 (T-cell leukemia homeobox 3) gene at 5q35 can be aberrantly expressed in T-cell acute lymphoblastic leukaemia (T- ALL) due to a cryptic translocation1.
Unlike TLX1, the dysregulation of TLX3 is not brought about by close juxtaposition with T-cell receptor genes, instead, it is brought into contact with another gene that is highly expressed in normal T-cell differentiation: BCL11B at 14q322. The t(5;14)(q35;q32) translocation is cryptic and the breakpoint does not actually disrupt TLX3 but, in the majority of cases, occurs within or downstream of the RANBP17 gene3. RANBP17 is very close to TLX3 and although its expression is not affected by the translocation, TLX3 expression is affected. The t(5;14)(q35;q32) translocation is found in approximately 20% of childhood T-ALL and 13% of adult cases. Rarer TLX3 rearrangements have also been reported: a t(5;7)(q35;q21) translocation involving CDK6 at 7q21 and a t(5;14)(q35;q11) translocation involving TRA/D at 14q11.21.
The quality of the products we have received from CytoCell have been excellent. The FISH probes they provide to us give intense, strong signals and are a pleasure to count. What has really stood out however has been the level of support and assistance provided by CytoCell’s application specialists. The team worked very closely alongside our own during the adoption of this product and spent many hours with us perfecting the technique, going above and beyond what I would expect during the transition period. Source BioScience absolutely demand high quality products and service to be able to deliver our results with confidence, and that is what we have received from CytoCell.
Laboratory Operations Manager, Source BioScience, UK